1. Home
  2. HALO vs APPF Comparison

HALO vs APPF Comparison

Compare HALO & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • APPF
  • Stock Information
  • Founded
  • HALO 1998
  • APPF 2006
  • Country
  • HALO United States
  • APPF United States
  • Employees
  • HALO N/A
  • APPF N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • APPF Computer Software: Prepackaged Software
  • Sector
  • HALO Health Care
  • APPF Technology
  • Exchange
  • HALO Nasdaq
  • APPF Nasdaq
  • Market Cap
  • HALO 7.4B
  • APPF 7.9B
  • IPO Year
  • HALO N/A
  • APPF 2015
  • Fundamental
  • Price
  • HALO $65.87
  • APPF $214.29
  • Analyst Decision
  • HALO Buy
  • APPF Buy
  • Analyst Count
  • HALO 9
  • APPF 6
  • Target Price
  • HALO $63.78
  • APPF $271.20
  • AVG Volume (30 Days)
  • HALO 2.0M
  • APPF 356.7K
  • Earning Date
  • HALO 05-06-2025
  • APPF 04-24-2025
  • Dividend Yield
  • HALO N/A
  • APPF N/A
  • EPS Growth
  • HALO 55.40
  • APPF 158.56
  • EPS
  • HALO 3.76
  • APPF 5.36
  • Revenue
  • HALO $1,084,306,000.00
  • APPF $824,474,000.00
  • Revenue This Year
  • HALO $20.06
  • APPF $20.11
  • Revenue Next Year
  • HALO $24.20
  • APPF $16.68
  • P/E Ratio
  • HALO $17.52
  • APPF $39.97
  • Revenue Growth
  • HALO 25.64
  • APPF 22.73
  • 52 Week Low
  • HALO $41.28
  • APPF $189.01
  • 52 Week High
  • HALO $70.51
  • APPF $274.56
  • Technical
  • Relative Strength Index (RSI)
  • HALO 58.99
  • APPF 49.40
  • Support Level
  • HALO $58.38
  • APPF $198.70
  • Resistance Level
  • HALO $70.51
  • APPF $217.75
  • Average True Range (ATR)
  • HALO 2.50
  • APPF 7.40
  • MACD
  • HALO 0.88
  • APPF 0.58
  • Stochastic Oscillator
  • HALO 64.61
  • APPF 53.73

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About APPF AppFolio Inc.

AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.

Share on Social Networks: